Galil Medical: Europe's First Symposium in Minimally Invasive Techniques in Urology Featuring Cryotherapy and Laser Innovations

This September, prior to the prestigious Societe Internationale
d'Urologie (SIU) Congress taking place from 2nd to 6th September,
Galil Medical is sponsoring Europe's first 'Advances in Minimally
Invasive Techniques in Urology' symposium.

Minimally invasive techniques are gaining momentum for the
management of both benign and malignant conditions and so this
exciting and interactive symposium is timely. The symposium is
dedicated to the latest advancements in cryoablation for treating
prostate and renal cancer and laser technologies for BPH, and will
feature live surgeries.

Dr Herve Baumert, part of the symposium's faculty and head of the
department of Urology at the Paris Saint Joseph Hospital Trust said:
"The goal of this symposium is to promote minimally invasive
cryotherapy and laser procedures for treating urological conditions by
bringing the newest technologic advancements to physicians."

The symposium is taking place on Saturday 1st September 2007 from
9.00am - 5pm at the Paris Saint Joseph Hospital Trust in Paris.
Physicians interested in learning about cutting edge therapeutic
medical devices for the treatment of prostate and renal cancer and BPH
are encouraged to attend. The symposium is sponsored by an educational
grant from Galil Medical, who will also be providing the equipment
along with Karl Storz and Lisa Laser Products.

An impressive faculty will be in attendance at the symposium and
includes:

-- Dr Tev Aho, Consultant Urologist, Addenbrooke's Hospital, UK

-- Dr Herve Baumert, Head of the department of Urology, Paris
Saint Joseph Hospital Trust, France

-- Prof John G Baust, Department of Biological Sciences,
Binghamton University, US

-- Dr Shmuel Cytron, Department of Urology, Barzilay Medical
Center, Askelon, Israel

-- Prof Jean De La Rosette, Director Centre for Minimal Invasive
Urology, University Medical Centre, St Radboud, The
Netherlands

-- Dr Olivier Dumonceau, Paris Saint Joseph Hospital Trust,
France

-- Prof Damian Greene, Consultant Urologist, Sunderland, UK

-- Mr Derek Jerome, from Galil Medical UK

-- Dr Pilar Laguna, Department of Urology, Academic Medical
Centre, Amsterdam, The Netherlands

-- Dr Stefano Mattioli, Urologist, Milan, Italy

-- Dr Vincent Molinie, Paris Saint Joseph hospital trust, France

-- Mr Heino Teichmann, from Germany

For further details and to register, please contact Helena Symeou
at hsdcommunications at helena.symeou@hsdcomm.com.

About Galil Medical

Galil Medical develops, manufactures and markets an innovative
cryotherapy platform incorporating powerful freezing technology and
revolutionary 17-gauge cryoablation needle design as a minimally
invasive alternative to surgery for various clinical applications. The
Presice(TM) Cryoablation System features multi-point thermal sensors
(MTS) and advanced IceVue(TM) planning and simulation software for
excellent procedure control and clinical results in treating prostate
and renal cancer. The SeedNet(TM) system provides physicians with an
easy-to-use solution to precisely ablate tissue while protecting
adjacent structures, ensuring rapid recovery and increased quality of
life for patients.

Galil Medical is a global medical device company with offices in
Yokneam, Israel; Plymouth Meeting, Pennsylvania; and London, United
Kingdom. Shareholders include Thomas, McNerney Partners, Vertical
Group, Investor Growth Capital, Elron Electronic industries
(NASDAQ:ELRN) and RDC Rafael Development Corporation, Ltd. For more
information, please visit www.galilmedical.com.